Abstract:Vaccines aim to elicit a robust, yet targeted, immune response. Failure of a vaccine to elicit such a response arises in part from inappropriate temporal control over antigen and adjuvant presentation to the immune system. In this work, we sought to exploit the immune system's natural response to extended pathogen exposure during infection by designing an easily administered slow-delivery vaccine platform. We utilized an injectable and self-healing polymer–nanoparticle (PNP) hydrogel platform to prolong the codelivery of vaccine components to the immune system. We demonstrated that these hydrogels exhibit unique delivery characteristics, whereby physicochemically distinct compounds (such as antigen and adjuvant) could be codelivered over the course of weeks. When administered in mice, hydrogel-based sustained vaccine exposure enhanced the magnitude, duration, and quality of the humoral immune response compared to standard PBS bolus administration of the same model vaccine. We report that the creation of a local inflammatory niche within the hydrogel, coupled with sustained exposure of vaccine cargo, enhanced the magnitude and duration of germinal center responses in the lymph nodes. This strengthened germinal center response promoted greater antibody affinity maturation, resulting in a more than 1000-fold increase in antigen-specific antibody affinity in comparison to bolus immunization. In summary, this work introduces a simple and effective vaccine delivery platform that increases the potency and durability of subunit vaccines.Injectable polymer−nanoparticle hydrogels provide a simple and effective platform for sustained delivery of subunit vaccines to increase the potency and durability of the humoral immune response.This article has not yet been cited by other publications.

Considerations for Size, Surface Charge, Polymer Degradation, Co‐Delivery, and Manufacturability in the Development of Polymeric Particle Vaccines for Infectious Diseases

Applications of polymer-based nanoparticles in vaccine field

Development of vaccine formulations: past, present, and future

Advances in the polymeric delivery of nucleic acid vaccines

Biological Nanoparticles in Vaccine Development

Biomaterials, biological molecules, and polymers in developing vaccines

Recent advances in nano- and micro-scale carrier systems for controlled delivery of vaccines

Biomaterials and nanomaterials for sustained release vaccine delivery

Multipolymer Microsphere Delivery of SARS-CoV-2 Antigens

Enhancing Vaccine Efficacy and Stability: A Review of the Utilization of Nanoparticles in mRNA Vaccines

Biodegradable nanoplatforms for antigen delivery: part I - state of the art review of polymeric nanoparticles for cancer immunotherapy

Current Progress in the Science of Novel Adjuvant Nano-Vaccine-Induced Protective Immune Responses

Polymeric Nanoparticles as a Self‐Adjuvanting Peptide Vaccine Delivery System: The Role of Shape

Polymeric Nanoparticles as Oral and Intranasal Peptide Vaccine Delivery Systems: The Role of Shape and Conjugation

Process Optimization of Scaled-Up Production and Biosafety Evaluation of the Dimethyl-Dioctadecyl-Ammonium Bromide/Poly(lactic acid) Nano-Vaccine

Advanced technologies for the development of infectious disease vaccines

Effects on immunization of the physicochemical parameters of particles as vaccine carriers

Administration Sequence- and Formulation-dependent Vaccination using Acid-degradable Polymeric Nanoparticles with High Antigen Encapsulation Capability

Nanoparticles in Subunit Vaccines: Immunological Foundations, Categories, and Applications

Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines

Injectable Hydrogels for Sustained Codelivery of Subunit Vaccines Enhance Humoral Immunity